NEW DELHI: Pharmaceutical experts and the medical technology sector are seeking extension of the production-linked incentive (PLI) scheme to cover active pharmaceutical ingredients (APIs). They also expect the government ...
Cyber Threats In 2025: Cyber threats have become a persistent global risk with far-reaching implications across industries. The financial stability of almost every sector is at stake, as evidenced ...
India has started manufacturing 38 active pharmaceutical ingredients, or APIs, in the last one and a half years on which it was import-dependent, under the production-linked incentive (PLI) scheme ...